| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,414 |
27,995 |
$1.60M |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
26,177 |
23,797 |
$1.02M |
| X5622 |
|
11,189 |
9,703 |
$587K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,576 |
5,129 |
$297K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,422 |
4,123 |
$293K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,711 |
12,328 |
$272K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,526 |
4,790 |
$248K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,205 |
3,917 |
$212K |
| 90461 |
|
7,337 |
6,573 |
$120K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,362 |
1,284 |
$98K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,620 |
1,511 |
$95K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,165 |
2,050 |
$71K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,718 |
4,474 |
$51K |
| 92551 |
|
9,560 |
8,692 |
$43K |
| 99000 |
|
4,752 |
4,401 |
$38K |
| 99188 |
|
5,320 |
4,802 |
$38K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,182 |
1,120 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,144 |
2,972 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,333 |
1,110 |
$27K |
| 95117 |
|
2,636 |
1,503 |
$17K |
| 87070 |
|
2,419 |
2,283 |
$13K |
| 99072 |
|
4,995 |
4,262 |
$13K |
| 83655 |
|
1,129 |
1,068 |
$12K |
| 90686 |
|
6,320 |
5,952 |
$11K |
| 96127 |
|
3,437 |
3,076 |
$11K |
| 36416 |
|
4,385 |
3,953 |
$11K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
226 |
220 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,779 |
5,392 |
$8K |
| 99460 |
|
132 |
130 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
76 |
76 |
$8K |
| 99173 |
|
7,970 |
7,136 |
$7K |
| 85027 |
|
1,437 |
1,304 |
$7K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
147 |
145 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
134 |
134 |
$5K |
| 85007 |
|
1,796 |
1,622 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,016 |
1,846 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
478 |
459 |
$4K |
| 85018 |
|
1,898 |
1,804 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
194 |
191 |
$3K |
| 80061 |
Lipid panel |
197 |
195 |
$2K |
| 90670 |
|
3,967 |
3,583 |
$2K |
| 96161 |
|
1,042 |
942 |
$1K |
| 90480 |
|
85 |
80 |
$1K |
| 90651 |
|
890 |
843 |
$1K |
| 90734 |
|
630 |
608 |
$1K |
| 99383 |
|
12 |
12 |
$946.20 |
| 90716 |
|
1,431 |
1,369 |
$664.17 |
| 81001 |
|
235 |
222 |
$663.25 |
| 94010 |
|
28 |
28 |
$483.65 |
| 90688 |
|
1,043 |
936 |
$434.80 |
| 90680 |
|
2,348 |
2,125 |
$406.12 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
131 |
124 |
$388.27 |
| 90656 |
|
178 |
175 |
$358.60 |
| 90698 |
|
3,697 |
3,347 |
$322.42 |
| 99070 |
|
229 |
223 |
$316.64 |
| 90707 |
|
1,217 |
1,158 |
$311.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
32 |
29 |
$257.24 |
| 0002A |
|
14 |
14 |
$247.76 |
| 90633 |
|
1,621 |
1,542 |
$240.47 |
| 0001A |
|
15 |
15 |
$209.70 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
18 |
13 |
$165.73 |
| 91321 |
|
55 |
54 |
$148.63 |
| 90697 |
|
54 |
54 |
$134.02 |
| 99384 |
|
16 |
15 |
$114.88 |
| 90744 |
|
1,723 |
1,588 |
$114.30 |
| 90715 |
|
215 |
205 |
$66.43 |
| 90696 |
|
274 |
271 |
$63.41 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,345 |
1,276 |
$56.04 |
| 82465 |
|
16 |
15 |
$5.68 |
| 90677 |
|
46 |
41 |
$0.04 |
| 90685 |
|
647 |
579 |
$0.00 |
| 91300 |
|
37 |
30 |
$0.00 |
| 90687 |
|
21 |
20 |
$0.00 |